» Articles » PMID: 38431946

Iron, Copper, and Magnesium Concentration in Hair and Risk of Esophageal Cancer: A Nested Case-Control Study

Overview
Journal Arch Iran Med
Specialty General Medicine
Date 2024 Mar 3
PMID 38431946
Authors
Affiliations
Soon will be listed here.
Abstract

Background: An association has already been hypothesized between iron, copper, and magnesium status assessed through food frequency questionnaires (FFQs) and the risk of esophageal squamous cell carcinoma (ESCC). However, self-reported dietary assessment methods are prone to measurement errors. We studied the association between iron, copper, and magnesium status and ESCC risk, using hair samples as a long exposure biomarker.

Methods: We designed a nested case-control study within the Golestan Cohort Study, that recruited about 50000 participants in 2004-2008, and collected biospecimens at baseline. We identified 96 incident cases of ESCC with available hair samples. They were age-matched with cancer-free controls from the cohort. We used inductively coupled plasma mass spectrometry (ICP-MS) to measure iron, copper, and magnesium concentrations in hair samples. We used multiple logistic regression models to determine odds ratios and 95% confidence intervals.

Results: Median concentrations of iron, copper, and magnesium were 35.4, 19.3, and 41.7 ppm in cases and 25.8, 18.3, and 50.0 ppm in controls, respectively. Iron was significantly associated with the risk of ESCC in continuous analysis (OR=1.41, 95% CI=1.03-1.92), but not in the tertiles analyses (OR=1.81, 95% CI=0.77-4.28). No associations were observed between copper and magnesium and ESCC risk, in either the tertiles models or the continuous estimate (copper: OR=2.56, 95% CI=1.00-6.54; magnesium: OR=0.75, 95% CI=0.32-1.78).

Conclusion: Higher iron status may be related to a higher risk of ESCC in this population.

Citing Articles

Iron and cancer: overview of the evidence from population-based studies.

Zeidan R, Yoon H, Yang J, Sobh A, Braithwaite D, Mankowski R Front Oncol. 2024; 14:1393195.

PMID: 39246326 PMC: 11377248. DOI: 10.3389/fonc.2024.1393195.

References
1.
Malekshah A, Kimiagar M, Saadatian-Elahi M, Pourshams A, Nouraie M, Goglani G . Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr. 2006; 60(8):971-7. DOI: 10.1038/sj.ejcn.1602407. View

2.
Chan K, Choi M, Lai K, Tan W, Tung L, Lam H . Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma. Oncol Rep. 2014; 31(3):1296-304. DOI: 10.3892/or.2014.2981. View

3.
Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo M, Dar N . International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol. 2017; 28(9):2086-2093. PMC: 5834011. DOI: 10.1093/annonc/mdx279. View

4.
Keszei A, Goldbohm R, Schouten L, Jakszyn P, van den Brandt P . Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Am J Clin Nutr. 2012; 97(1):135-46. DOI: 10.3945/ajcn.112.043885. View

5.
Venturelli S, Leischner C, Helling T, Renner O, Burkard M, Marongiu L . Minerals and Cancer: Overview of the Possible Diagnostic Value. Cancers (Basel). 2022; 14(5). PMC: 8909570. DOI: 10.3390/cancers14051256. View